Home > News > Recent cases

Glaxo Wellcome & anor v Sandoz & ors [2019] EWHC 1528 (Pat)12 June 2019Martin Howe QC, Iona Berkeley and Ashton Chantrielle appeared for the First to Fifth Defendants in this pre-trial review, in passing off proceedings relating to the colour and get-up of the Claimants’ Seretide combination inhaler. The principal issue to be determined at the pre-trial review was the Defendants’ application to exclude certain parts of the […]
Technetix BV v Teleste [2019] EWHC 928 (Pat)3 April 2019James Mellor QC appeared for the Defendant, Teleste, in this pre-trial review in a patent action. At the pre-trial review the Claimants, Technetix, made, inter alia, an unconditional application to amend their patent. The Claimants’ unconditional amendment sought to delete Claim 1 of the patent and to amend Claim 2 as a matter of form […]
PulseOn OY v Garmain (Europe)Ltd [2019] EWCA Civ 13813 February 2019James Mellor QC and Maxwell Keay appeared for the Appellant, PulseOn, in their appeal against a finding that two registered community designs (RCDs) depicting aspects of design of heart monitor devices had not been infringed by the Respondents. The trial judge had found that the RCDs were valid but had not been infringed by the […]
Beauty Bay v Benefit Cosmetics [2019] EWHC 1150 (Ch)11 February 2019James Abrahams QC and Maxwell Keay appeared for the Claimants (Beauty Bay) while Jessie Bowhill appeared for the Defendant (Benefit). This was a claim for trade mark infringement and passing off relating to the marks “BEAUTY BAY” and “BEAUTYBAY”, registered in respect of cosmetics and retail services connected with cosmetics. The claim arose out of […]
Regen Lab SA v Estar Medical and ors [2019] EWHC 63 (Pat)18 January 2019Andrew Lykiardopoulos QC appeared alongside Michael Conway and Tim Bamford of Collyer Bristow, for the Claimant (“Regen”), in this action concerning Regen’s patent for the preparation of platelet rich blood plasma (PRP). Regen claimed that that the patent was infringed by the Defendant’s PRP kits. The Defendants (“Estar”) denied infringement and counterclaimed for revocation, alleging […]